Pharmacokinetic Properties of Single and Multiple Doses of Ertugliflozin, a Selective Inhibitor of SGLT2, in Healthy Chinese Subjects

Ertugliflozin, a sodium‐glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes mellitus, prevents renal glucose reabsorption resulting in urinary glucose excretion. This open‐label, parallel cohort, randomized study conducted in healthy Chinese adults residing in China assessed the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yinhua, Mu, Yuting, Shi, Haihong, Liang, Yali, Liu, Zeyuan, Matschke, Kyle, Hickman, Anne, Krishna, Rajesh, Sahasrabudhe, Vaishali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003779/
https://www.ncbi.nlm.nih.gov/pubmed/30934166
http://dx.doi.org/10.1002/cpdd.686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003779/
https://www.ncbi.nlm.nih.gov/pubmed/30934166
http://dx.doi.org/10.1002/cpdd.686

Ejemplares similares